SIHUAN PHARM_Providing professional financial news and data related to SIHUAN PHARM, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

SIHUAN PHARM (00460.HK): Repurchases 10 million shares for about HKD 8.111 million; H1 net profit up 221% year on year

Tags：

SIHUAN PHARM 00460.HK Share Buyback

2026-08-27

SIHUAN PHARM(00460.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 224.7 million, YoY increase of 119%

Tags：

SIHUAN PHARM 00460.HK profit growth

2026-08-26

SIHUAN PHARM (00460.HK): Miao Guili resigns as executive director and CFO, Che Yuxuan appointed non-executive director and Song Xiaomi appointed CFO

Tags：

SIHUAN PHARM 00460.HK resignation

2026-08-26

SIHUAN PHARM(00460.HK): First Patient Dosed in Phase III Trial of Anaprazole Sodium from Xuanzhu Biologics for Helicobacter Pylori Eradication

Tags：

SIHUAN PHARM 00460.HK Clinical Trial

2026-06-22

SIHUAN PHARM (00460.HK): 6 New Specifications of Collagen Stimulating Filler Approved, Improving Regenerative Aesthetic Medicine Product Matrix

Tags：

SIHUAN PHARM 00460.HK

2026-01-16

Scan QR Code

Download App